• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sirtex Medical Ltd

+ Add to Watchlist


28.1500 AUD 0.4500 1.57%

As of 22:10:48 ET on 12/23/2014.

Snapshot for Sirtex Medical Ltd (SRX)

Open: 28.8500 Day's Range: 27.8600 - 28.8500 Volume: 89,874
Previous Close: 28.6000 52wk Range: 11.3500 - 29.4900 1-Yr Rtn: +145.47%

Stock Chart for SRX

No chart data available.
  • SRX:AU 28.1500
  • 1D
  • 1M
  • 1Y
Interactive SRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRX

Current P/E Ratio (ttm) 65.8634
Estimated P/E(06/2015) 49.3860
Relative P/E vs. AS51 3.6439
Earnings Per Share (AUD) (ttm) 0.4274
Est. EPS (AUD) (06/2015) 0.5700
Est. PEG Ratio 1.6798
Market Cap (M AUD) 1,591.33
Shares Outstanding (M) 56.53
30 Day Average Volume 289,776
Price/Book (mrq) 14.6812
Price/Sale (ttm) 12.0505
Dividend Indicated Gross Yield 0.71%
Cash Dividend (AUD) 0.1400
Dividend Ex-Date 10/03/2014
5 Year Dividend Growth 14.87%
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SRX

Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.

Gilman WongCEO/Exec Dir/Mng DirDarren SmithCFO/Secretary
David CadeChief Medical OfficerNigel LangeCEO:Europe
More Company Profile & Key Executives for SRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil